# PROPANC BIOPHARMA INC COM NEW

PROPANC BIOPHARMA INC COM NEW is a security (CUSIP 74346N701) tracked across SEC portfolio filings. 6 institutional managers reported $45K on Form 13F as of 2026-03-31.

## Summary

- Issuer: PROPANC BIOPHARMA INC
- Class: COM NEW
- CUSIP: 74346N701
- 13F holders: 6
- 13F value: $45K
- 13F period: 2026-03-31
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| UBS Group AG | Zurich, V8 | $19K | 182,614 |
| JANE STREET GROUP, LLC | NEW YORK, NY | $15K | 143,212 |
| Marex Group plc | London, X0 | $7K | 67,724 |
| Sassicaia Capital Advisers LLC | JERICHO, NY | $2K | 16,000 |
| XTX Topco Ltd | LONDON, X0 | $1K | 12,098 |
| Virtu Financial LLC | New York, NY | $4 | 40,748 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/74346N701.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.